Exploring sociodemographic and economic factors that promote adverse drug reactions reporting by patients

Pedro Inácio, João José Gomes, Marja Airaksinen and Afonso Cavaco

Health Policy, 2018, vol. 122, issue 3, 263-268

Abstract: Adverse drug reactions (ADRs) are recognized as a leading cause of morbidity and mortality, and an important cost factor to health systems. Patient reporting of ADRs has emerged as an important topic in recent years but reporting rates are still low in many countries.

Keywords: Pharmacovigilance; Adverse drug reactions reporting systems; Health policy; Quality of health care; Patient reported outcome measures; Adverse drug reactions (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851017302932
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:122:y:2018:i:3:p:263-268

DOI: 10.1016/j.healthpol.2017.10.004

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().